Literature DB >> 10631652

ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis.

A Chiò1.   

Abstract

In a number of ALS patients, a long delay between onset of symptoms and diagnosis is reported. In this international study (ISIS Survey) we have identified the pathway followed by ALS patients from first symptoms to diagnosis confirmation. Diagnostic data from a total of 201 patients with definite ALS from 6 countries (Argentina, Brazil, Germany, Italy, Spain and the USA) were analyzed. The median time needed to confirm diagnosis was found to be 14 months; time to first consultation took 2 months, time to consultation with a neurologist took 8 months, and time for observation and diagnostic assessment by the neurologist took 4 months. This time delay was shorter when presentation was at bulbar level and when fasciculations were present. The major causes of diagnostic delay were unfamiliarity of the physician with the disease, unusual clinical presentation, coexistence of other diseases to which clinical symptomatology was attributed, misleading findings or misinterpretation of neuro-radiological or neurophysiological findings. The diagnostic delay has several implications for patients and their families, including mismanagement, delay in establishing appropriate and individualized pharmacological and symptomatic therapies, and difficulty in planning personal and familiar future.

Entities:  

Mesh:

Year:  1999        PMID: 10631652     DOI: 10.1007/bf03161081

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  13 in total

1.  Misdiagnosis in patients with amyotrophic lateral sclerosis.

Authors:  J M Belsh; P L Schiffman
Journal:  Arch Intern Med       Date:  1990-11

2.  Role of electromyography in amyotrophic lateral sclerosis.

Authors:  M Behnia; J J Kelly
Journal:  Muscle Nerve       Date:  1991-12       Impact factor: 3.217

3.  Diagnosis of motor neuron disease by neurologists: a study in three countries.

Authors:  T M Li; M Swash; E Alberman; S J Day
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

4.  Physiologic and metabolic response to progressive and prolonged exercise in amyotrophic lateral sclerosis.

Authors:  M Sanjak; D Paulson; R Sufit; W Reddan; D Beaulieu; L Erickson; A Shug; B R Brooks
Journal:  Neurology       Date:  1987-07       Impact factor: 9.910

5.  The amyotrophic lateral sclerosis (ALS) patient perspective on misdiagnosis and its repercussions.

Authors:  J M Belsh; P L Schiffman
Journal:  J Neurol Sci       Date:  1996-08       Impact factor: 3.181

6.  El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors.

Authors:  B R Brooks
Journal:  J Neurol Sci       Date:  1994-07       Impact factor: 3.181

7.  Recent developments in the drug treatment of motor neurone disease.

Authors:  R W Orrell; R J Lane; R J Guiloff
Journal:  BMJ       Date:  1994-07-16

Review 8.  Palliative therapy in the terminal stage of neurological disease.

Authors:  R Voltz; G D Borasio
Journal:  J Neurol       Date:  1997-10       Impact factor: 4.849

9.  Undiagnosed amyotrophic lateral sclerosis and respiratory failure.

Authors:  M J Kuisma; K V Saarinen; H T Teirmaa
Journal:  Acta Anaesthesiol Scand       Date:  1993-08       Impact factor: 2.105

10.  Onset, natural history and outcome in idiopathic adult motor neuron disease.

Authors:  F Norris; R Shepherd; E Denys; K U; E Mukai; L Elias; D Holden; H Norris
Journal:  J Neurol Sci       Date:  1993-08       Impact factor: 3.181

View more
  25 in total

1.  Amyotrophic lateral sclerosis mimic syndrome due to a dorsal spinal cord neurofibroma.

Authors:  Andrea Calvo; Franco Benech; Paolo Ghiglione; Michele Balma; Cristina Moglia; Roberto Mutani; Adriano Chio
Journal:  Neurol Sci       Date:  2010-02       Impact factor: 3.307

Review 2.  Impairments in Motor Neurons, Interneurons and Astrocytes Contribute to Hyperexcitability in ALS: Underlying Mechanisms and Paths to Therapy.

Authors:  Dzung Do-Ha; Yossi Buskila; Lezanne Ooi
Journal:  Mol Neurobiol       Date:  2017-02-03       Impact factor: 5.590

3.  Utility of dissociated intrinsic hand muscle atrophy in the diagnosis of amyotrophic lateral sclerosis.

Authors:  Parvathi Menon; Steve Vucic
Journal:  J Vis Exp       Date:  2014-03-04       Impact factor: 1.355

Review 4.  Clinical diagnosis and management of amyotrophic lateral sclerosis.

Authors:  Orla Hardiman; Leonard H van den Berg; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

5.  Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS).

Authors:  Sabrina Paganoni; Eric A Macklin; Alexandra Lee; Alyssa Murphy; Judith Chang; Amanda Zipf; Merit Cudkowicz; Nazem Atassi
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-07-01       Impact factor: 4.092

6.  Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis.

Authors:  Stefan Sivák; Michal Bittšanský; Egon Kurča; Monika Turčanová-Koprušáková; Milan Grofik; Vladimír Nosál'; Hubert Poláček; Dušan Dobrota
Journal:  Neuroradiology       Date:  2010-04-06       Impact factor: 2.804

7.  Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis.

Authors:  Arianna Sala; Leonardo Iaccarino; Piercarlo Fania; Emilia G Vanoli; Federico Fallanca; Caterina Pagnini; Chiara Cerami; Andrea Calvo; Antonio Canosa; Marco Pagani; Adriano Chiò; Angelina Cistaro; Daniela Perani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-07       Impact factor: 9.236

8.  Genes and Environmental Exposures in Veterans with Amyotrophic Lateral Sclerosis: the GENEVA study. Rationale, study design and demographic characteristics.

Authors:  Silke Schmidt; Kelli D Allen; Valerie T Loiacono; Barbara Norman; Catherine L Stanwyck; Kristina M Nord; Christina D Williams; Edward J Kasarskis; Freya Kamel; Valerie McGuire; Lorene M Nelson; Eugene Z Oddone
Journal:  Neuroepidemiology       Date:  2008-04-18       Impact factor: 3.282

Review 9.  Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis.

Authors:  Sabrina Paganoni; Chafic Karam; Nanette Joyce; Richard Bedlack; Gregory T Carter
Journal:  NeuroRehabilitation       Date:  2015       Impact factor: 2.138

Review 10.  Cost effectiveness of treatments for amyotrophic lateral sclerosis: a review of the literature.

Authors:  Gary Ginsberg; Serena Lowe
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.